Trevena, Inc. - Common Stock (TRVN)

Trevena Inc is a biopharmaceutical company that focuses on developing innovative therapies to treat various central nervous system disorders and acute pain conditions

The company leverages its proprietary drug discovery platform to create novel molecules that target specific receptors in the brain and nervous system, aiming to provide safer and more effective treatment options. By prioritizing patient safety and reducing reliance on opioids, Trevena is actively exploring advanced therapies that can improve the quality of life for patients suffering from difficult-to-treat medical conditions.